Zhang Hui, Liu Xiaoqiu, Xu Caihong, Hu Dongmei, Li Xue, Li Tao, Zhao Yanlin, Chen Mingting, Liu Jianjun
National Center for Tuberculosis Control and Prevention, China CDC, Beijing, China.
China CDC Wkly. 2020 Dec 4;2(49):948-950. doi: 10.46234/ccdcw2020.236.
Tuberculosis (TB) is a global public health problem, especially in China. China has the third largest TB burden in the world with nearly 0.9 million new TB cases emerging annually. Despite impressive achievements, China still faces many challenges in TB control that threaten further progress and the ability to meet the targets of the End TB strategy if not addressed. On July 15, 2019, the State Council of China issued Healthy China Initiative 2019-2030, which proposed 15 special campaigns including the Tuberculosis Control Action to guide the way for China's TB prevention and control. This article introduces the current status of TB in China, achievements reached so far, and challenges remaining and interprets the targets and strategies from the individual, society, and government level in the Tuberculosis Control Action.
结核病是一个全球性的公共卫生问题,在中国尤为如此。中国的结核病负担位居世界第三,每年新增近90万例结核病病例。尽管取得了令人瞩目的成就,但中国在结核病防控方面仍面临诸多挑战,如果不加以解决,这些挑战将威胁到进一步的进展以及实现终结结核病战略目标的能力。2019年7月15日,中国国务院发布了《健康中国行动(2019—2030年)》,其中提出了包括结核病防治行动在内的15项专项行动,为中国的结核病预防和控制指明了方向。本文介绍了中国结核病的现状、迄今取得的成就、仍然存在的挑战,并从个人、社会和政府层面解读了结核病防治行动中的目标和策略。